F

Fate Therapeutics
D

FATE

1.68000
USD
-0.20
(-10.64%)
مغلق
حجم التداول
0
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
191,342,479
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    B
    BLUE
    -0.51500
    (-5.75%)
    8.44000 USD
    C
    CLLS
    -0.03000
    (-1.78%)
    1.66000 USD
    C
    CRSP
    -3.490
    (-7.83%)
    41.110 USD
    E
    EDIT
    -0.17500
    (-11.51%)
    1.34500 USD
    N
    NTLA
    -1.110
    (-8.45%)
    12.020 USD
    S
    SGMO
    -0.48000
    (-17.02%)
    2.34000 USD
    V
    VYGR
    -0.44500
    (-7.13%)
    5.80000 USD
    المزيد
الأخبار

العنوان: Fate Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.